Evidence map›Paper›PMID 37996448›Full record

ArticleScientific reports2023

Phenogrouping and risk stratification of patients undergoing cardiac resynchronization therapy upgrade using topological data analysis.

Walter Richard Schwertner, Márton Tokodi, Boglárka Veres, Anett Behon, Eperke Dóra Merkel, Richárd Masszi, Luca Kuthi, Ádám Szijártó, Attila Kovács, István Osztheimer and 7 more

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Walter Richard Schwertner *Heart and Vascular Center, Semmelweis University, 68 Városmajor Street, 1122, Budapest, Hungary.
Márton Tokodi *Heart and Vascular Center, Semmelweis University, 68 Városmajor Street, 1122, Budapest, Hungary.
Boglárka VeresHeart and Vascular Center, Semmelweis University, 68 Városmajor Street, 1122, Budapest, Hungary.
Anett BehonHeart and Vascular Center, Semmelweis University, 68 Városmajor Street, 1122, Budapest, Hungary.
Eperke Dóra MerkelHeart and Vascular Center, Semmelweis University, 68 Városmajor Street, 1122, Budapest, Hungary.
Richárd MassziHeart and Vascular Center, Semmelweis University, 68 Városmajor Street, 1122, Budapest, Hungary.
Luca KuthiHeart and Vascular Center, Semmelweis University, 68 Városmajor Street, 1122, Budapest, Hungary.
Ádám SzijártóHeart and Vascular Center, Semmelweis University, 68 Városmajor Street, 1122, Budapest, Hungary.
Attila KovácsHeart and Vascular Center, Semmelweis University, 68 Városmajor Street, 1122, Budapest, Hungary.
István OsztheimerHeart and Vascular Center, Semmelweis University, 68 Városmajor Street, 1122, Budapest, Hungary.
Endre ZimaHeart and Vascular Center, Semmelweis University, 68 Városmajor Street, 1122, Budapest, Hungary.
László GellérHeart and Vascular Center, Semmelweis University, 68 Városmajor Street, 1122, Budapest, Hungary.
Máté VámosCardiac Electrophysiology Division, Department of Internal Medicine, University of Szeged, Szeged, Hungary.
László SághyCardiac Electrophysiology Division, Department of Internal Medicine, University of Szeged, Szeged, Hungary.
Béla MerkelyHeart and Vascular Center, Semmelweis University, 68 Városmajor Street, 1122, Budapest, Hungary. merkely.study@gmail.com.
Annamária KosztinHeart and Vascular Center, Semmelweis University, 68 Városmajor Street, 1122, Budapest, Hungary.
Dávid BeckerHeart and Vascular Center, Semmelweis University, 68 Városmajor Street, 1122, Budapest, Hungary.

Funding

Ministry for Innovation and Technology in Hungary NVKP_16-1-2016-0017 ('National Heart Program')Ministry for Innovation and Technology in Hungary RRF-2.3.1-21-2022-00004Ministry for Innovation and Technology in Hungary ÚNKP-21-3-II-SE-47 and ÚNKP-20-3-I-SE-43
6 · The paper itself

Abstract

Choosing the optimal device during cardiac resynchronization therapy (CRT) upgrade can be challenging. Therefore, we sought to provide a solution for identifying patients in whom upgrading to a CRT-defibrillator (CRT-D) is associated with better long-term survival than upgrading to a CRT-pacemaker (CRT-P). To this end, we first applied topological data analysis to create a patient similarity network using 16 clinical features of 326 patients without prior ventricular arrhythmias who underwent CRT upgrade. Then, in the generated circular network, we delineated three phenogroups exhibiting significant differences in clinical characteristics and risk of all-cause mortality. Importantly, only in the high-risk phenogroup was upgrading to a CRT-D associated with better survival than upgrading to a CRT-P (hazard ratio: 0.454 (0.228-0.907), p = 0.025). Finally, we assigned each patient to one of the three phenogroups based on their location in the network and used this labeled data to train multi-class classifiers to enable the risk stratification of new patients. During internal validation, an ensemble of 5 multi-layer perceptrons exhibited the best performance with a balanced accuracy of 0.898 (0.854-0.942) and a micro-averaged area under the receiver operating characteristic curve of 0.983 (0.980-0.986). To allow further validation, we made the proposed model publicly available ( https://github.com/tokmarton/crt-upgrade-risk-stratification ).

Indexed as

Cardiac Resynchronization TherapyDefibrillators, ImplantableHeart FailurePacemaker, ArtificialArrhythmias, CardiacHumansRisk AssessmentTreatment Outcome

Identifiers

PMID37996448
PMCPMC10667223

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.